Both warfarin and digoxin have a narrow therapeutic window, thus there is a relatively high possibility of drugdrug interactions
Even if patients have appropriate glycemic control, their medication regimen may not be optimal based on co-morbidities
Extracerebral effects of glucagon-like peptide-1 receptor agonists Glycemic impact of GLP-1RAs Hyperglycemia has a causal impact on increased risk of ischemic stroke [19]
Undark asked Holt and Nathan Downing, an attorney with Gardner Law who specializes in FDA law, to review several examples of language used by clinics
After propensity score matching, patients prescribed a GLP-1 RA had significantly increased risk of new chronic cough compared with patients prescribed any nonGLP-1 RA second-line medication, dipeptidyl peptidase-4 inhibitor, or sulfonylurea
Myocardial ischemia-reperfusion injury: a neglected therapeutic target